US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Dengue Market Research Reports & Industry Analysis

Find the information you need on Dengue infectious disease, clinical trials and drug development. Our collection of market research reports provides insights into product and market trends, analysis, opportunities, projections, sales, and marketing strategies. Specifics on market share, segmentation, size, and growth in the US and global markets are also featured.
RSS Feeds

Dengue Industry Research & Market Reports

Global Tropical Disease Partnering 2010 to 2016
4/1/2016 | published by: Current Partnering
... Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides ...  |  read more...
USD 1,495
Global Dengue Fever Partnering 2010 to 2016
4/1/2016 | published by: Current Partnering
... Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides ...  |  read more...
USD 1,495
Dengue Fever Pipeline Highlights – 2016
12/16/2015 | published by: Fore Pharma
... Dengue Fever in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and ...  |  read more...
USD 680
Dengue-Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. ...  |  read more...
USD 1,250
Dengue Fever Global Clinical Trials Review, H1, 2016
1/20/2016 | published by: GlobalData
... line data relating to the clinical trials on Dengue Fever. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical ...  |  read more...
USD 2,500
Global Dengue Fever Partnering 2010-2015
7/1/2015 | published by: Current Partnering
... deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Dengue fever Partnering 2010-2015 provides understanding and access to the dengue fever partnering deals and agreements entered into by ...  |  read more...
USD 1,495
Dengue - Pipeline Review, H2 2015
7/15/2015 | published by: Global Markets Direct
... Dengue, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Dengue Virus - Pipeline Review, 2015
9/14/2015 | published by: GlobalData
... information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in ...  |  read more...
USD 2,500
Dengue - Pipeline Review, H1 2015
1/22/2015 | published by: Global Markets Direct
... Dengue, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
EpiCast Report: Dengue - Epidemiology Forecast to 2023
5/5/2014 | published by: GlobalData
... most prevalent arthropod-borne diseases affecting humans. The severity of dengue fever ranges from asymptomatic cases, to classic dengue fever, and to DHF or DSS. GlobalData epidemiologists sourced government-based publications for the forecast of reported laboratory-confirmed ...  |  read more...
USD 3,995
Dengue Fever Partnering 2010-2015
5/1/2015 | published by: Current Partnering
... deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Dengue fever Partnering 2010-2015 provides understanding and access to the dengue fever partnering deals and agreements entered into by ...  |  read more...
USD 1,495
Dengue Global Clinical Trials Review, H1, 2015
4/27/2015 | published by: GlobalData
... relating to the clinical trials on Dengue. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage ...  |  read more...
USD 2,500
OpportunityAnalyzer: Dengue Vaccines - Opportunity Analysis and Forecasts to 2020 - Event-Driven Update
9/30/2014 | published by: GlobalData
... aegypti (A. aegypti) mosquito. Thought to be responsible for upwards of 100 million infections each year, DENV is the most prevalent arthropod-borne virus in the world. Individuals infected with DENV can present with a wide ...  |  read more...
USD 7,995
OpportunityAnalyzer: Dengue Vaccines - Opportunity Analysis and Forecasts to 2020
7/14/2014 | published by: GlobalData
... mosquito. Thought to be responsible for upwards of 100 million infections each year, DENV is the most prevalent arthropod-borne virus in the world. Individuals infected with DENV can present with a wide spectrum of symptoms, ...  |  read more...
USD 7,995
What's Next In Vaccines (Malaria, Diabetes, Alzheimer's, Allergies and 30 Other Targets in the 2012-2021 Vaccine Pipeline)
6/5/2012 | published by: Kalorama Information
... examines and estimates the market for vaccines that have yet to be launched.    What diseases may see a prophylactics vaccine option in the coming years? Which vaccines will have the most successful business model? Who are ...  |  read more...
USD 3,995
Dengue - Pipeline Review, Q1 2011
3/29/2011 | published by: Global Markets Direct
... with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Dengue. 'Dengue - Pipeline Review, Q1 2011' is built using data and information ...  |  read more...
USD 500
MarketVIEW: Dengue vaccines
7/1/2012 | published by: VacZine Analytics
... death as observed in dengue haemorrhagicfever (DHF) and dengue shock syndrome (DSS). Importantly, of the 22,000 estimated deaths per year, the large majority are inchildren ( Although the search for a dengue vaccine has been ...  |  read more...
USD 10,995
A Product and Pipeline Analysis of the Latin American HIV, Chagas, Dengue, and Influenza H1N1 Therapeutics Markets
10/15/2013 | published by: Frost & Sullivan
... the human immunodeficiency virus (HIV), Chagas, dengue, and influenza H1N1 therapeutics markets in Latin America. General market trends are covered, and a competitive landscape, which highlights current drugs on the market as well as drugs ...  |  read more...
USD 3,950
Update: Dengue Fever Pipeline Highlights – 2014
5/1/2014 | published by: Fore Pharma
... therapies for Dengue Fever in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development ...  |  read more...
USD 590
Dengue Global Clinical Trials Review, H2, 2013
9/30/2013 | published by: GlobalData
... relating to the clinical trials on Dengue. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage ...  |  read more...
USD 2,500